Phenylpropanolamine increases plasma caffeine levels

Publisher Website
Google Scholar
Abstract
The effects of the widely consumed drugs caffeine and phenylpropanolamine are mediated through activation of the central and sympathetic nervous systems. Severe, life-threatening, and occasionally fatal hypertensive reactions have been reported after their combined use. This study examined the possible pharmacokinetic interaction of phenylpropanolamine and caffeine. Sixteen normal subjects received combinations of caffeine, phenylpropanolamine, and placebo. In subjects receiving 400 mg cafferine plus 75 mg phenylpropanolamine, the mean (.+-. SEM) peak plasma caffeine concentration of 8.0 .+-. 2.2 .mu.g/ml was significantly greater than after 400 mg caffeine alone (2.1 .+-. 0.3 .mu.g/ml; t[24] = 2.4; p < 0.01). Physical side effects were more frequent after the phenylpropanolamine-caffeine combination than after either drug alone or after placebo. Greater increases in both systolic and diastolic blood pressures occurred after the combination than after either drug alone. Because caffeine levels can be increased greatly when certain other drugs are coconsumed, these data indicate that phenylpropanolamine may enhance absorption or inhibit elimination of caffeine and may explain increased side effects reported after their combined use.

This publication has 21 references indexed in Scilit: